Literature DB >> 28449450

Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence.

Antonin Levy1,2,3, Olaf Mercier2,4, Cécile Le Péchoux1.   

Abstract

Entities:  

Year:  2017        PMID： 28449450      PMCID： PMC5393992          DOI： 10.21037/jtd.2017.03.25

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

Review 1.  Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.

Authors:  Francesca Soldà; Mark Lodge; Sue Ashley; Alastair Whitington; Peter Goldstraw; Michael Brada
Journal:  Radiother Oncol       Date:  2013-10-12       Impact factor: 6.280

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Authors:  J Vansteenkiste; L Crinò; C Dooms; J Y Douillard; C Faivre-Finn; E Lim; G Rocco; S Senan; P Van Schil; G Veronesi; R Stahel; S Peters; E Felip
Journal:  Ann Oncol       Date:  2014-02-20       Impact factor: 32.976

4.  SBRT Dose and Survival in Non-Small Cell Lung Cancer: In Regard to Koshy et al.

Authors:  Antonin Levy; Matthias Guckenberger; Coen Hurkmans; Ursula Nestle; José Belderbos; Dirk De Ruysscher; Corinne Faivre-Finn; Cécile Le Péchoux
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-15       Impact factor: 7.038

5.  Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.

Authors:  Yukinori Matsuo; Fengshi Chen; Masatsugu Hamaji; Atsushi Kawaguchi; Nami Ueki; Yasushi Nagata; Makoto Sonobe; Satoshi Morita; Hiroshi Date; Masahiro Hiraoka
Journal:  Eur J Cancer       Date:  2014-09-30       Impact factor: 9.162

6.  Impact of lymph node occult metastases in stage I non-small cell lung cancer (NSCLC): what is the evidence?

Authors:  Giuseppe Marulli; Marco Mammana; Federico Rea
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 7.  Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Binglan Zhang; Fuping Zhu; Xuelei Ma; Ye Tian; Dan Cao; Songe Luo; Yu Xuan; Lei Liu; Yuquan Wei
Journal:  Radiother Oncol       Date:  2014-09-15       Impact factor: 6.280

8.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

9.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

Review 10.  Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Gang Li; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  Eur J Cardiothorac Surg       Date:  2017-02-01       Impact factor: 4.534
View more
  1 in total

1.  Pattern of recurrence after CyberKnife stereotactic body radiotherapy for peripheral early non-small cell lung cancer.

Authors:  Masaki Nakamura; Ryo Nishikawa; Hiroshi Mayahara; Haruka Uezono; Aya Harada; Naoki Hashimoto; Hideki Nishimura
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.